Acrogenomics announces full MV acquisition plan

Swiss technology development group Acrongenomics has agreed a timeline for the full acquisition of UK-based diagnostics firm Molecular Vision. Earlier this month, the former purchased 10.9% of the latter's shares and, as a result of the new agreement, intends to buy the remainder before the end of the first quarter.

Acrogenomics said that Molecular Vision, a spin out from Imperial College, was developing technology that combined microfluidics and light responsive polymers in a way that could revolutionize the point-of-care diagnostics market. Having previously invested $4.6 million in a prototype developed by the the UK firm, Acrogenomics said that the acquisition was the next logical step.